Skip to main content
Caplight Logo









Astrin Biosciences

Astrin Biosciences

Private
Saint Paul, MinnesotaHealthcare & Life Scienceshttps://astrinbio.com

Last Round

VC Round

Jun 11, 2024

Total Funding Raised

$399,678

Company Overview

Astrin Biosciences is a biotechnology company that develops diagnostic tools designed for early cancer detection and precision therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Medical Devices, Precision Medicine, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

liquid biopsycancer diagnosticsbreast cancer screeningearly cancer detectionnon-invasive diagnosticsdeep proteomicsAI diagnosticsproteomics platformmolecular diagnosticslaboratory-developed testLDTdense breast tissueCLIA lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Astrin Biosciences Comparables

Compare Astrin Biosciences with similar companies based on industry and business-model similarity.

Astrin Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mammogen
89%
Syantra Inc.
87%
Bcal Diagnostics Ltd
77%

Astrin Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 11, 2024
GrantJun 1, 2022

Key People

Founding team and executive leadership

Jayant Parthasarathy

Chief Executive Officer

Executive Team

Jiarong Hong

Chief Technology Officer

Executive Team

Astrin Biosciences Investors

Notable investors and investment history

Astrin Biosciences investors
InvestorRounds
National Cancer InstituteGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2025

    New board will support AI-enabled proteomics platform development.

  • Dec 1, 2025

    Developing an AI-enabled proteomics platform for early cancer detection.

Astrin Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Astrin Biosciences Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSaint Paul, Minnesota
Employee Range25
Year Founded2020
Last FundingJun 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?